NATIONAL MEDICINE AND VACCINE SHORTAGES
QUESTIONNAIRE
Background: Shortages of medicines and vaccines is a complex global problem, with documented supply failure of medicines and
vaccines being reported in countries at all levels of development, across every region of the world.
In response to World Health Assembly (WHA) resolution WHA69.25, “Addressing the Global Shortage of Medicines and Vaccines”,
the World Health Organization (WHO) is gathering information to assess the magnitude and nature of the problem of medicine and
vaccine shortages and to identify strategies that are likely to improve the current situation.
The focus of this investigation is medicine and vaccine supply side shortages.
Objectives: The aim of this questionnaire is to gain a more comprehensive understanding of strategies used by countries to
mitigate the risk of shortages and to assess to what extent shortages impact delivery of optimal health care to patients.
Notes:
Please complete the questionnaire by indicating your answers to the best of your knowledge.
If supporting documents are available (e.g. legislations), kindly send them together with the questionnaire or indicate where the
document can be found (e.g. web link).
After completing the questionnaire, please send directly to Tifenn Humbert, Technical Officer, Health Technologies and
Pharmaceuticals Programme, DSP, WHO EURO at
[email protected] ; and CC
[email protected];
[email protected] and
[email protected] no later than 25 June 2018.
Name of Country: Estonia Name of Organization: State Agency of Medicines
Name of contact person: Klara Saar Title of contact person: Ms
Email address of contact person:
Date: 06.06.2018
[email protected]
1. NOTIFICATION ABOUT SHORTAGES OR POTENTIAL SHORTAGES
Is there a national mechanism for market authorization holders (or others) to notify the country authority(ies) in case of likely
disruption of supply of medicines and vaccines?
☒ Yes No Not known
Is reporting a shortage to the responsible authority(ies) Voluntary Not known
voluntary or mandatory for market authorization holders? ☒ Mandatory
Which national authority(ies) are responsible for
implementation and/or enforcement of this requirement (e.g. State Agency of Medicines
the NMRA, the national medical store etc.)?
In Estonia marketing authorization holders are obliged to report a
Please estimate how many times the entities indicated in the shortage. 127 shortages were reported in 2016 and 112 shortages in
list to the right reported shortages to the responsible 2017. The reports were made by marketing authorization holders or their
authority(ies) over the last 12 and 24 months? authorized representatives, however, some of them have also an activity
license for wholesale distribution and/or manufacture of medicinal
products.
If
Do reporting mechanisms request information on estimated ☒ Yes No Not Known
yes:
duration of the shortage If yes ☒ Start date; ☒ End date; ☒ Duration (weeks, months etc.)
Do reporting mechanisms request the entities to provide ☒ Yes Not known
relevant authority(ies) with status updates including resolution
of shortage? No
Are entities required to give advance notice of expected
shortages or only report at the start of a shortage?
A shortage must be reported at least 2 months in advance, except in
If the former, please indicate the minimum amount of time exceptional circumstances.
before the anticipated shortage that entities are required to
report (e.g. at least 3 months before anticipated shortage)
Do reporting mechanisms request information on causes of the ☒ Yes Not known
shortage (e.g. manufacturing, demand changes etc.)? No
☒ Yes Not known
If a global notification system existed, would your country No
consider using such a system? If no, please explain. [If no, please explain why (e.g. competing priorities, legislative
constraints etc.]
In all ☒ Identification of medicine/vaccine (INN, Tradename, Dosage form,
cases Strength, Name of manufacturer/supplier, manufacturing site, ATC code)
If you had access to a global notification system, please ☒ Shortage status (Start date of shortage, Resolution date if known)
indicate from the list to the right which information you would
☒ Reason for shortage
find most useful?
Resolution strategy/plan
Alternate strength or presentation available
☒ Information on alternative sources available
How likely is it that the information listed above could be
Very likely ☒ Likely Not likely Not known
contributed by your country to a global notification system.
2. MEDICINE AND VACCINE WATCH LIST
Is there a national watch list (such as a national list of Vital, Essential and Non-essential medicines and vaccines (VEN)) that a
national authority actively monitors for availability?
Yes ☒ No
State Agency of Medicines has made an overview of the medicinal
products marketed in Estonia which do not have any alternatives
available (no other medicinal products containing the same active
Could you please attach a copy of the current list.
substance in same dosage strength or dosage form). This list has been
sent to marketing authorization holders and wholesalers for awareness
and careful planning of manufacture and distribution.
If Yes Not known
Is this list used to determine which medicines’ and vaccines’
yes: No
shortage should be reported to the authorities?
[If no, please indicate the criteria used to decide which medicines’ and
vaccines’ shortages should be reported on.]
3. RESPONSE TO SHORTAGES
Is action taken by the authorities or other actors once notified about a shortage or potential shortage?
☒ Yes No
☒ Yes Not known
No
Are there policies and procedures that describe actions that
authorities are expected or able to take when notified of State Agency of Medicines has developed an in-house standard
different types of shortages? operation procedure for managing shortage reports. The procedure is
specified in the State Agency of Medicines’ Job Description of the senior
inspector.
An in-house form is filled with the shortage information.
A shortage notification containing product information, expected
shortage duration, available alternatives and suggestion for patients to
If contact doctor (if necessary) is published on the web page of State
What actions are most frequently taken by authorities in
yes: Agency of medicines.
responding to a reported shortage?
If applicable, the MAH will be contacted and asked about the possibility
to distribute the medicinal product in another European Economic Area
language packaging.
An export restriction is considered.
Does legislation(s) or any other provision(s) exist to support
special or flexible procedures to authorize or register
medicines and vaccines that have gone into shortage? (e.g. for Yes, a labelling exemption is possible.
a medicine in shortage, an emergency or limited authorization http://www.ravimiamet.ee/en/exemptions-labelling-and-package-leaflet-
may be given to an equivalent product, but with flexibilities on obligations-estonia
normal labeling requirements)
4. COMMUNICATION OF SHORTAGES
Is information about shortages communicated to healthcare providers, program managers, consumers and/or other key
stakeholders?
☒ Yes No
State Agency of Medicines publishes the notifications of shortages on the
Does the national authority communicate information on agency’s web page. These notifications are also available through the
shortages to all relevant stakeholders, or is information RSS feed to all subscribers.
disseminated through channels (e.g., state or district If necessary, the physicians and professional organizations of doctors
authorities)? will be additionally notified by the State Agency of Medicines or by the
marketing authorization holders.
What are the mechanisms and the frequency of communication?
If A notification is published on the web page of State Agency of Medicines
(e.g. letters sent after each shortage report or information
yes: after every shortage report.
uploaded on website once a month)
The biggest problem is to receive sufficient information about the
shortage from the marketing authorization holders. Also, majority of the
What are the key challenges in communicating information to
shortages are reported less than 2 months in advance. This is often too
health care providers, program managers, consumers and other
short time to find alternative measures and provide continuous supply of
key stakeholders?
the medicinal product for the patients. A common reason for shortages is
inaccurate planning of manufacture or distribution.
5. IMPACT OF SHORTAGES
In your opinion do shortages of medicines and vaccines in your country pose a significant public health problem?
☒ Yes No
If Have there been any recent national or subnational reports on There are no such reports; however, managing shortages is a problem
yes: shortages? If so, please attach a copy. for healthcare professionals.
Antibiotics ☒ Severe Moderate Manageable
Other anti-infectives Severe ☒ Moderate Manageable
Oncology medication ☒ Severe Moderate Manageable
Based on information available to you, including informal Emergency medication ☒ Severe Moderate Manageable
information, which of the following levels of severity best Mental health medication Severe ☒ Moderate Manageable
describes the impact that shortages of medicines and vaccines Cardiovascular medication Severe ☒ Moderate Manageable
have in the delivery of healthcare in your country. Anesthetic medication Severe ☒ Moderate Manageable
Vaccines ☒ Severe Moderate Manageable
Other [please name] Severe Moderate Manageable
……………………………………………………………………………………………………
Sterile injectables Severe ☒ Moderate Manageable
In your opinion, has the incidence of shortages of essential ☒ Increased No opinion
In all medicines and vaccines in your country increased, decreased or
Decreased
cases: remained the same over the last 12 months?
No change
Thank you for taking the time to complete this questionnaire.
NATIONAL MEDICINE AND VACCINE SHORTAGES
QUESTIONNAIRE
Background: Shortages of medicines and vaccines is a complex global problem, with documented supply failure of medicines and
vaccines being reported in countries at all levels of development, across every region of the world.
In response to World Health Assembly (WHA) resolution WHA69.25, “Addressing the Global Shortage of Medicines and Vaccines”,
the World Health Organization (WHO) is gathering information to assess the magnitude and nature of the problem of medicine and
vaccine shortages and to identify strategies that are likely to improve the current situation.
The focus of this investigation is medicine and vaccine supply side shortages.
Objectives: The aim of this questionnaire is to gain a more comprehensive understanding of strategies used by countries to
mitigate the risk of shortages and to assess to what extent shortages impact delivery of optimal health care to patients.
Notes:
Please complete the questionnaire by indicating your answers to the best of your knowledge.
If supporting documents are available (e.g. legislations), kindly send them together with the questionnaire or indicate where the
document can be found (e.g. web link).
After completing the questionnaire, please send directly to Tifenn Humbert, Technical Officer, Health Technologies and
Pharmaceuticals Programme, DSP, WHO EURO at
[email protected] ; and CC
[email protected];
[email protected] and
[email protected] no later than 25 June 2018.
Name of Country: Name of Organization:
Name of contact person: Title of contact person:
Email address of contact person: Date:
1. NOTIFICATION ABOUT SHORTAGES OR POTENTIAL SHORTAGES
Is there a national mechanism for market authorization holders (or others) to notify the country authority(ies) in case of likely
disruption of supply of medicines and vaccines?
Yes No Not known
Is reporting a shortage to the responsible authority(ies) Voluntary Not known
voluntary or mandatory for market authorization holders? Mandatory
Which national authority(ies) are responsible for
[Please name all national entities responsible for implementation and/or
implementation and/or enforcement of this requirement (e.g.
enforcement of requirement of reporting of shortages]
the NMRA, the national medical store etc.)?
Overseas manufacturers [Please indicate number of reports]
Please estimate how many times the entities indicated in the Local manufacturers [Please indicate number of reports]
list to the right reported shortages to the responsible Importers [Please indicate number of reports]
authority(ies) over the last 12 and 24 months? Wholesalers [Please indicate number of reports]
Retailers [Please indicate number of reports]
Others [Please name and indicate number of reports]
If
yes: Do reporting mechanisms request information on estimated Yes No Not Known
duration of the shortage If yes Start date; End date; Duration (weeks, months etc.)
Do reporting mechanisms request the entities to provide Yes Not known
relevant authority(ies) with status updates including resolution
of shortage? No
Are entities required to give advance notice of expected
shortages or only report at the start of a shortage? [Please indicate if reports need to be made in advance of a shortage or
at the time of a shortage. If in advance of a shortage please indicate
If the former, please indicate the minimum amount of time minimum time requirement specifying if there are different reporting
before the anticipated shortage that entities are required to time requirements for different medicines and vaccines]
report (e.g. at least 3 months before anticipated shortage)
Do reporting mechanisms request information on causes of the Yes Not known
shortage (e.g. manufacturing, demand changes etc.)? No
Yes Not known
If a global notification system existed, would your country No
consider using such a system? If no, please explain. [If no, please explain why (e.g. competing priorities, legislative
constraints etc.]
Identification of medicine/vaccine (INN, Tradename, Dosage form,
In all Strength, Name of manufacturer/supplier, manufacturing site, ATC code)
cases
Shortage status (Start date of shortage, Resolution date if known)
If you had access to a global notification system, please
indicate from the list to the right which information you would Reason for shortage
find most useful? Resolution strategy/plan
Alternate strength or presentation available
Information on alternative sources available
How likely is it that the information listed above could be
Very likely Likely Not likely Not known
contributed by your country to a global notification system.
2. MEDICINE AND VACCINE WATCH LIST
Is there a national watch list (such as a national list of Vital, Essential and Non-essential medicines and vaccines (VEN)) that a
national authority actively monitors for availability?
Yes No
Could you please attach a copy of the current list. [Please attach document or web link]
If Yes Not known
Is this list used to determine which medicines’ and vaccines’
yes: No
shortage should be reported to the authorities?
[If no, please indicate the criteria used to decide which medicines’ and
vaccines’ shortages should be reported on.]
3. RESPONSE TO SHORTAGES
Is action taken by the authorities or other actors once notified about a shortage or potential shortage?
Yes No
Yes Not known
Are there policies and procedures that describe actions that No
authorities are expected or able to take when notified of [If no, please describe how authorities decide on action in response to
different types of shortages? shortages.
If yes, kindly attach any key documents or web links]
What actions are most frequently taken by authorities in [Please list the most frequent actions that the authorities take in
If responding to a reported shortage? responding to reported shortages]
yes:
Does legislation(s) or any other provision(s) exist to support
special or flexible procedures to authorize or register
medicines and vaccines that have gone into shortage? (e.g. for
[Please indicate whether such legislation or provision exists and if so
a medicine in shortage, an emergency or limited authorization
kindly attach a copy or provide a web link]
may be given to an equivalent product, but with flexibilities on
normal labeling requirements)
4. COMMUNICATION OF SHORTAGES
Is information about shortages communicated to healthcare providers, program managers, consumers and/or other key
stakeholders?
Yes No
Does the national authority communicate information on
[Please describe if all key stakeholders are notified of all shortages by
shortages to all relevant stakeholders, or is information
the national authority(ies) or is there a cascading communication
disseminated through channels (e.g., state or district
strategy]
authorities)?
If What are the mechanisms and the frequency of communication?
[Please indicate the mechanism by which different stakeholders are
yes: (e.g. letters sent after each shortage report or information
notified and whether this is routine action or only in special cases]
uploaded on website once a month)
What are the key challenges in communicating information to [Please describe the main challenges in communicating information to
health care providers, program managers, consumers and other different stakeholders both in regards to level of information and
key stakeholders? mechanisms of communication]
5. IMPACT OF SHORTAGES
In your opinion do shortages of medicines and vaccines in your country pose a significant public health problem?
Yes No
[please indicate if any such reports have been produced by the NMRA,
Have there been any recent national or subnational reports on
NGOs, development partners or industry and if so kindly suggest how we
shortages? If so, please attach a copy.
may be able to obtain a copy]
Antibiotics Severe Moderate Manageable
Other anti-infectives Severe Moderate Manageable
Oncology medication Severe Moderate Manageable
If Based on information available to you, including informal Emergency medication Severe Moderate Manageable
yes: information, which of the following levels of severity best Mental health medication Severe Moderate Manageable
describes the impact that shortages of medicines and vaccines Cardiovascular medication Severe Moderate Manageable
have in the delivery of healthcare in your country. Anesthetic medication Severe Moderate Manageable
Vaccines Severe Moderate Manageable
Other [please name] Severe Moderate Manageable
……………………………………………………………………………………………………
Sterile injectables Severe Moderate Manageable
In your opinion, has the incidence of shortages of essential Increased No opinion
In all medicines and vaccines in your country increased, decreased or
Decreased
cases: remained the same over the last 12 months?
No change
Thank you for taking the time to complete this questionnaire.